Author:
Hadizadeh Nastaran,Bagheri Diba,Shamsara Mehdi,Hamblin Michael R.,Farmany Abbas,Xu Mengdi,Liang Zhuobin,Razi Farideh,Hashemi Ehsan
Abstract
The main goals of medicine consist of early detection and effective treatment of different diseases. In this regard, the rise of exosomes as carriers of natural biomarkers has recently attracted a lot of attention and managed to shed more light on the future of early disease diagnosis methods. Here, exosome biogenesis, its role as a biomarker in metabolic disorders, and recent advances in state-of-art technologies for exosome detection and isolation will be reviewed along with future research directions and challenges regarding the manipulation and genetic engineering of exosomes for potential in vitro and in vivo disease diagnosis approaches.
Subject
Biomedical Engineering,Histology,Bioengineering,Biotechnology
Reference242 articles.
1. Natural killer cells: Development, maturation, and clinical utilization;Abel;Front. Immunol.,2018
2. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid;Admyre;Eur. Respir. J.,2003
3. Exosomes with immune modulatory features are present in human breast milk;Admyre;J. Immunol.,2007
4. Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice;Agouni;PLoS ONE,2011
5. Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies;Akers;J. Neurooncol.,2013
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献